Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68131


Purpose:

An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhinometry will be used to measure the congestion.


Criteria:

Inclusion Criteria: - Male or female subjects 19-55 years with allergic rhinitis requiring treatment within the previous 2 years. - Subjects that respond to a ragweed nasal allergen challenge at screening. Exclusion Criteria: - History of asthma or FEV1 < 80% predicted. - Significant concomitant disease or medications. - Symptoms of allergic rhinitis within 2 weeks prior to screening.


NCT ID:

NCT00562120


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

Omaha, Nebraska 68131
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.